{"nct_id":"NCT04280081","title":"A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2020-03-16","start_date_type":"ACTUAL","primary_completion_date":"2021-03-25","primary_completion_date_type":"ACTUAL","completion_date":"2027-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["LLY"]}